source
- AI biotech Fathom raises $47M Series A, renames from AtommapIn the early 2000s, way before AI became a ubiquitous buzzword in biotech, billionaire scientist David Shaw was building supercomputers to study molecules at his eponymous research company. Huafeng…Endpoints · 3mo ago↗ source
- STAT+: Veradermics’ hair loss drug succeeds in late-stage trialThe company is one of the most advanced players in the hair loss field, which has seen a surge of investor enthusiasm.STAT · 3mo ago↗ source
- STAT+: Oruka’s long-acting psoriasis therapy posts strong results in mid-stage studyA long-acting injectable treatment for plaque psoriasis helped 63% of patients achieve complete skin clearance in a clinical trial, its maker, Oruka Therapeutics, reported.STAT · 3mo ago